Melanoma Institute of Australia’s Melanoma March returns

An Australian not-for-profit organisation is calling on Tasmanians to join its campaign to raise awareness and funds to combat one of the country’s biggest killers.

26 August 2020 – MPA Webinar Series

Event #1 – Wed 26th August from 7pm to 830pm Topics: Dermatology and Melanoma Surgery Please register via the Eventbrite link: https://www.eventbrite.com.au/e/dermatology-and-melanoma-surgery-a-discussion-with-our-specialists-registration-116189932215?aff=ebdssbeac >> DOWNLOAD PDF for full details

Melanoma survivors march to honour lost friends and raise awareness

Melanoma has a reputation for being one of the most curable types of cancers, but that does not mean much to survivors such as Jay Allen and Aaron Kelly.

Free skin checks for South West community

The Bunbury Skin Cancer Clinic is partnering with melanomaWA to provide the community with free skin checks on February 24.

Cancer in the News

Feature Articles

New research finds nearly a third of melanomas found during skin checks may not be harmful, improving treatment options

Melanoma is among the most commonly diagnosed cancers in Australia.

READ MORE >

Posted in Melanoma News, Patients, Latest News

Study finds a link between aging and cancer metastases

Spreading cancer cells that escape a primary tumor site can seed in tissues distant from the tumor, but may take several years or decades to grow into full metastatic cancers.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest

InterVenn Biosciences Announces New Data Validating the Clinical Performance of DAWN™ IO Melanoma as a Novel Liquid Biopsy Test to Improve Assessment of Benefit to Cancer Patients

SAN FRANCISCO–(BUSINESS WIRE)–InterVenn® Biosciences, a clinical technology company leveraging glycoproteomics to transform the future of healthcare, today announced new data showing that its new DAWN IO Melanoma test accurately assesses and classifies advanced melanoma patients as likely or unlikely to benefit from immune checkpoint inhibitor therapies: either pembrolizumab alone or ipilimumab in combination with nivolumab.

READ MORE >

Posted in Melanoma News, Health Professionals, Clinical Trials

10 Factors That Will Shape the Future of Skin Cancer Treatment

Will drinking caffeinated coffee reduce skin cancer risk? Is gene expression profiling set to become mainstream testing for melanoma? See what Darrell S. Rigel, MD, MS, FAAD, has to say.

READ MORE >

Posted in Melanoma News, Health Professionals, Of Interest